In recent years, the multidrug resistant bacteria market is anticipated to grow rapidly during the forecast period. As per the Centers for Disease Control and Prevention (CDC), around 1.7 million illnesses and 99,000 related fatalities occur each year in American hospitals, according to the CDC. Additionally, the infection disease rate is expected to develop due to an increase in demand for point-of-care testing. In the future years, these factors are projected to influence the growth of the worldwide multidrug resistant bacteria market.
